Ibandronate and Antiestrogens Work Together Against Breast Cancer Cells
Author Information
Author(s): Fabrice Journe, Carole Chaboteaux, Nicolas Magne, Hugues Duvillier, Guy Laurent, Jean-Jacques Body
Primary Institution: Institut J Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, Brussels, Belgium
Hypothesis
Does ibandronate enhance the effects of antiestrogens in estrogen receptor-positive breast cancer cells?
Conclusion
Ibandronate shows additive effects with antiestrogens in inhibiting the growth of estrogen receptor-positive breast cancer cells.
Supporting Evidence
- Ibandronate inhibited cancer cell growth in a dose- and time-dependent manner.
- It completely abolished the mitogenic effect induced by 17β-estradiol in ER+ breast cancer cells.
- Ibandronate enhanced the growth inhibitory action of antiestrogens in estrogen-sensitive breast cancer cells.
Takeaway
Ibandronate can help stop breast cancer cells from growing, especially when used with other cancer-fighting drugs called antiestrogens.
Methodology
The study examined the effects of ibandronate on breast cancer cell lines in steroid-free medium and assessed its interaction with antiestrogens.
Limitations
The study was conducted in vitro, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website